Login / Signup
Upcoming first-line chemotherapy for HER2-negative gastric cancer in Japan: which patients benefit from immunotherapy?
Daisuke Takahari
Keisho Chin
Kensei Yamaguchi
Published in:
Future oncology (London, England) (2020)
Keyphrases
</>
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors